ISCHEMIA-CKD EXTEND: After 8 Years, Routine Invasive Care Did Not Improve Survival in Advanced CKD With Stable Coronary Disease
Eight-year follow-up of the ISCHEMIA-CKD trial, presented at AHA Scientific Sessions 2026 and published in Circulation, found no difference in all-cause or cardiovascular mortality between an initial invasive strategy and initial medical therapy in 777 people with advanced CKD and at least moderate